>

VanEck Vectors Profile

BBH

Performance

5 / 100

Odds of Distress

Analyze Filter   Check how we calculate scores
Equity ratings for VanEck Vectors Biotech ETF are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 23, 2019 and ending today February 21, 2020. Click here to learn more.

VanEck Vectors Profile

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. VanEck Vectors is traded on BATS Exchange in USA. more on VanEck Vectors
Legal NameVanEck Vectors Biotech ETF
ChairmanPhilip HornigView All
Thematic Classification
Currently Active Investing Idea
  Healthcare Funds
View All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
IssuerVan Eck
DescriptionVanEck Vectors Biotech ETF
Inception Date2011-12-20
BenchmarkMarket Vectors US Listed Biotech 25 Index
Entity TypeRegulated Investment Company
Asset Under Management365.46 Million
Average Trading Valume16,672.8
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionGlobal
AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Portfolio ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End31-Oct
ExchangeNASDAQ
Number of Constituents25.0
Market MakerVirtu Financial
Total Expense0.39
Management Fee0.35
Nav Price144.7
Two Hundred Day Average130.85
Ytd-5.04%
Average Daily Volume In Three Month15.02k
Fifty Two Week Low113.89
As Of DateJanuary 31, 2020
Average Daily Volume Last 10 Day12.96k
Fifty Two Week High144.96
One Month-5.04%
Fifty Day Average139.4
Three Month5.08%
VanEck Vectors Biotech ETF [BBH] is traded in USA and was established 2011-12-20. The fund is classified under Health category within VanEck family. The entity is thematically classified as Healthcare Funds. VanEck Vectors Biotech currently have 343.76 M in assets under management (AUM). , while the total return for the last 3 years was 5.6%.
Check VanEck Vectors Probability Of Bankruptcy

Geographic Allocation (%)

Top Etf Constituents

VanEck Vectors Target Price Odds Analysis

Odds Below 143.43HorizonTargetOdds Above 143.43
91.27%30 days 143.43 8.52%
Based on normal probability distribution, the odds of VanEck Vectors to move above current price in 30 days from now is about 8.52 (This VanEck Vectors Biotech ETF probability density function shows the probability of VanEck Vectors Etf to fall within a particular range of prices over 30 days) .

VanEck Vectors Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Group One Trading LpCall Options3.5 M102.6 M
Jpmorgan Chase CoPut Options1.7 M68.5 M
Ubs Group AgFund Units46.1 K6.4 M
View VanEck Vectors Diagnostics

VanEck Vectors Biotech Risk Profiles

VanEck Vectors Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. VanEck Vectors Price Ceiling Movement function is a real number to the largest previous price integer. View also all equity analysis or get more info about price ceiling movement math transform indicator.

VanEck Vectors Against Markets

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

VanEck Vectors Distributions to stockholders

Continue to Trending Equities. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.
Company logos by clearbit